Empowering Primary Care Through Evidence

PEER is a primary care led evidence based medicine team focused on providing relevant evidence to family physicians and primary care providers.

PEIP 2022 - Registration now open!

The PEER team is pleased to announce the 11th annual Practical Evidence for Informed Practice (PEIP) conference October 21-22, 2022. Join us for entertaining evidence-based reviews of clinically relevant primary care topics.


In Person and Online | Sept 22 – 24th, 2022

Evidence based navigation of northern medicine. Join the PEER team and local faculty in person or via webcast for the inaugural PEER-North conference, Sept 22-24, 2022 Yellowknife NWT.


CFPCLearn’s primary care focused library includes a variety of content including evidence summaries, videos, podcasts and interactive learning courses to support clinicians in their practice.

Most Recent Tools for Practice

Tools for Practice #232 – How to Slow the Flow II

In premenopausal heavy menstrual bleeding due to benign etiology, do levonorgestrel intrauterine systems (IUD) improve patient outcomes?

Compared to other treatments (example oral contraceptives), blood loss with an IUD is reduced ~80% versus 25%, more women with an IUD are satisfied (75% versus 60%), and more remain on treatment at 2 years (64% versus 38%). Read More

Tools for Practice #322 – A dose a day keeps the UTI away?

What is the efficacy of antibiotic prophylaxis for recurrent urinary tract infections (UTI) in non-pregnant women?

Antibiotic prophylaxis decreases the risk of recurrent UTIs from 66% with placebo to 12% with prophylaxis over 6-12 months. More women will experience an adverse event with antibiotics (15% versus 8% with placebo). Long-term bacterial resistance and its individual clinical impact has not been well studied Read More

Tools for Practice #321 – “Not Milk?”: Avoiding lactose-containing products during acute pediatric diarrhea

Do lactose-containing formulas/diets worsen acute pediatric diarrhea?

Breastfed children should continue breastfeeding. In formula-fed children under two years, temporarily switching to lactose-free infant formula shortens diarrhea duration by ~18 hours and reduces treatment failure (9% versus ~17% control) at 24-72 hours. The effects of cow’s milk are investigated in only three small, older randomized controlled trials and results are likely unreliable Read More

Tools for Practice #320 – Oh Baby: Combined oral contraceptives during breastfeeding

Do combined oral contraceptives (COCs) affect breastfeeding or infant outcomes?

Trials are older (>35 years), small (<300 mom/infants) and highly unreliable. If results are real, COCs may lower infant growth (by~240g) and rates of exclusive breastfeeding (81% versus 92%) compared to placebo at 90 days. Progestin-only pill (POP) evidence is inconsistent/unreliable. If results are real, infant growth is not different compared to placebo. If early postpartum contraception is desired, guidelines recommend progestin-only methods due to increased venous thromboembolism risk. Read More

Tools for Practice #319 – Should a ‘flozin’ be chosen? Part 2: SGLT2 inhibitors in patients with chronic kidney disease

What are the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on patient-relevant outcomes in chronic kidney disease (CKD)?

For every 100 patients with CKD treated with an SGLT2i for 5 years, ~3-4 fewer will develop end-stage kidney disease (ESKD) and ~3-4 fewer will die from any cause compared to placebo. Sotagliflozin is not better than placebo for these outcomes. Read More

PEER Values

When creating primary care education and programs, the PEER team focuses on minimizing bias, patient orientated outcomes, shared decision making, collaboration and most importantly simplicity.

Who is PEER?

Patients, Experience, Evidence and Research (PEER) was formed between a group of primary care providers who shared a common belief that evidence should be made accessible to all primary care providers. 

Follow @peerevidence on Instagram

Our Partners

Sign Up for the PEER Newsletter

Don’t miss out on the latest from PEER. Get first access the latest PEER research and notified when PEER releases new guidelines and tools.